Carlyne M. Averell, MS

Articles by Carlyne M. Averell, MS

Real-World Users of Triple Therapy for Asthma in the US

ByNadia N. Hansel, MD,Carl B. Abbott, PharmD,Carlyne M. Averell, MS,Guillaume Germain, MSc,François Laliberté, MA,Malena Mahendran, MSc,Mei S. Duh, ScD,Russell A. Settipane, MD

February 9th 2024

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.

Latest Updated Articles

Real-World Users of Triple Therapy for Asthma in the US
February 9th 2024

Carlyne M. Averell, MS

Articles by Carlyne M. Averell, MS

Real-World Users of Triple Therapy for Asthma in the US

Latest Updated Articles

Trending on AJMC

Ebola Cases Top 1700 as Unpaid Health Workers Strike

FDA Approves Atacicept for IgA Nephropathy

340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs

Quest Adds Haystack MRD to OncoEMR for Community Oncology

FDA Expands Approval for VWD Prophylaxis in Children Younger Than 6

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Carlyne M. Averell, MS

Articles by Carlyne M. Averell, MS

Real-World Users of Triple Therapy for Asthma in the US

Latest Updated Articles

Trending on AJMC

Ebola Cases Top 1700 as Unpaid Health Workers Strike

FDA Approves Atacicept for IgA Nephropathy

340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs

Quest Adds Haystack MRD to OncoEMR for Community Oncology

FDA Expands Approval for VWD Prophylaxis in Children Younger Than 6